tenk.fyi

Larimar Therapeutics, Inc.

LRMRNasdaq· Pharmaceutical Preparations

Price History

Revenue

-

Net Income

-$165.7M

105.5% YoY

EPS

-

Cash

$85.4M

157.1% YoY

FY 2025 · As of 2025-12-31

No recent insider transactions found.

ProShowing last 90 days. Full 12+ month history available on Pro.
Upgrade